This psychedelics play has been selling off after announcing a private placement at .40. Just out of oversold area and close to completing a bullish MACD cross. My guess is that some of the financing participants are selling their .40 shares and keeping the free .50 warrant which creates an opportunity to get in at discount to financing. Management is highly promotional. They managed to run it up 4x following the previous financing. Could see something similar play out, especially if psychedelics sector gets hot again.
Note
Open gap at .46.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.